Livin promotes Th2-type immune response in airway allergic diseases.

Authors:
Wang Y; Xiang Z; An M; Jia H; Bu C and 8 more

Journal:
Immunol Res

Publication Year: 2022

DOI:
10.1007/s12026-022-09294-9

PMCID:
PMC9499890

PMID:
35717553

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Immunol Res

Abbreviation: Immunol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoinflammatory diseases and the kidney.
Hegazy MT; Fayed A; Nuzzolese R and 2 more (2023) - Transparency Score: 3/6
Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
Iervasi E; Strangio A; Greco L and 2 more (2023) - Transparency Score: 3/6
COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case rep…
Syrmou V; Liaskos C; Ntavari N and 6 more (2023) - Transparency Score: 3/6
COVID-19 vaccines adverse events: potential molecular mechanisms.
Lamprinou M; Sachinidis A; Stamoula E and 2 more (2023) - Transparency Score: 2/6
Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis ba…
Huang X; Shentu H; He Y and 4 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThis study protocol was reviewed and approved by the Ethics Committees of the Second Hospital of Shanxi Medical University(approval number: 2019YX NO.085). Informed consentWritten informed consent was obtained from all participants. Conflict of InterestThe authors have no competing interests. Conflict of Interest The authors have no competing interests."

Evidence found in paper:

"Funding This work was supported by National Natural Science Foundation of China(Grant Number 81970865 and 81870707); Natural Science Foundation of Shanxi Province(Grant Number 201901D111387); and Research Project Supported by Shanxi Scholarship Council of China(Grant Number 2021–172)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025